1. Increasing diversity in clinical trials: overcoming critical barriers;Clark;Curr. Probl. Cardiol.,2019
2. Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials;U.S. Department of Health and Human Services, Food and Drug Administration, Oncology Center of Excellence (OCE), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH), Office of Minority Health and Health Equity (OMHHE),2022